Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Interim Immunization Protocol (RSV)
2025
· Oregon Health Authority
The Interim Immunization Protocol for RSV vaccines Abrysvo, Arexvy, and mResvia outlines guidelines for use. It describes the vaccine schedule, who should get vaccinated (pregnant …
Childhood Vaccines: What Immunizations Are Recommended and At What Age?
2025
· NewYork-Presbyterian
This article explains the importance of childhood vaccines and following the recommended immunization schedule. Dr. Melissa Stockwell, a pediatric expert, assures that vaccines are safe …
Making Vaccine Decisions During Pregnancy: What to Know
This newsletter describes the importance of four vaccines during pregnancy: influenza, COVID-19, Tdap, and RSV. These vaccines protect both mothers and babies from severe diseases. …
Should You Get an RSV Vaccine?
2025
· Yale University
This news article describes the importance of getting an RSV vaccine, especially for older adults and babies. RSV is a virus that can cause serious …
Respiratory Syncytial Virus Vaccine and Nirsevimab Uptake Among Pregnant People and Their Neonates
This study was conducted to describe the uptake of the prenatal RSVpreF vaccine and infant nirsevimab during the 2023-2024 RSV season. It found high uptake …
Maternal RSVpreF and Infant Nirsevimab Immunizations Uptake During Respiratory Syncytial Virus Season
This research letter looks at a study that analyzed the uptake of RSVpreF vaccination during pregnancy and nirsevimab administration to infants during the 2023 to …
Uptake of Maternal RSV Vaccination and Infant Nirsevimab Among Infants Born October 2023 to March 2024
2025
· Kaiser Permanente
The article investigates the uptake of maternal RSV vaccination and infant nirsevimab among infants born from October 2023 to March 2024 within Kaiser Permanente Northern …
Improving Palivizumab Administration to High-Risk Infants with Heart Disease via a Communication-Based Quality Improvement Initiative
2025
· Yale University,
· Yale New Haven Health System
This article describes a project to improve the administration of palivizumab, a medication for high-risk infants with heart disease. A team at Yale University worked …